A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program could run into problems with voluntary participation and concerns about ...

Diet weight loss company Noom announced it is launching a new program dubbed the Noom Microdose GLP-1Rx Program, which will provide members with personalized microdoses of GLP-1 medication. The ...

People with serious mental illness have higher rates of overweight and obesity, and obesity-related illnesses can worsen psychiatric symptoms. A 6-month fully remote weight-loss program tailored to ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

PORTSMOUTH, Va. (WAVY) — The holidays are here and with it comes unwanted extra weight and can be hard to eliminate. There are lots of options available for weight loss, but it’s important to stay ...

Gov. Kelly Ayotte is defending her decision that starting Jan. 1, the state Medicaid program will no longer pay for clients to receive so-called GLP-1 drugs such as Wegovy or Ozempic solely for weight ...

Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...